-
Sidra Medicine Becomes First Hospital in Qatar to Administer Revolutionary Gene Therapy Medication Life-saving drug from Roche Pharmaceuticals now available in Qatar for children with Duchenne Muscular Dystrophy Chris El Kik becomes first patient to receive treatment for DMD Doha, Qatar, 1 Ju… Continue Reading.....
-
Accurate and Timely Diagnoses Now a Reality with Whole Genome Sequencing at Sidra Medicine Hope for Patients with Complex Medical Conditions and Rare Diseases 30 June 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, is pleased to announce that it has successfully impleme… Continue Reading.....
-
Sidra Medicine Celebrates Second Medical Education Day QF Entity recognizes 2023-2024 academic batch of residents, fellows and sponsored students. 09 June 2024, Doha, Qatar – Sidra Medicine, a member of Qatar Foundation, celebrated its second Medical E… Continue Reading.....
-
Sidra Medicine Hosts Inaugural Conference on Primary Immune Dysregulation Disorders 15 May 2024, Doha, Qatar – Sidra Medicine, in collaboration with the MENAT-NIAID initiative, proudly hosted the Recent Advances in Primary Immunodysregulation Disorders (RAPID) conference on the 9th a… Continue Reading.....
-
Sidra Medicine to Establish Qatar’s First-Ever Pediatric Hematopoietic Stem Cell Transplant Program QF Entity Partners with Children’s Hospital of Philadelphia 14 May 2024, Doha, Qatar – Sidra Medicine, a QF entity, is proud to announce the upcoming establishment of the first-ever pediatric hemat… Continue Reading.....
-
Sidra Medicine Leads Largest Research on Rare Genetic Disease Risk in the Middle East 22 April 2024, Doha, Qatar – A study by Sidra Medicine, a member of Qatar Foundation, on rare genetic diseases in a wide-ranging and diverse Middle Eastern cohort from Qatar, has been published in the… Continue Reading.....